Cargando…
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
Ulcerative colitis (UC) still has no definitive cure since its etiology remains unclear. In recent years, considerable progress has been made with regard to our knowledge of the pathogenesis of UC. Advances in biotechnology have led to the development of biologic therapies which selectively target s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497489/ https://www.ncbi.nlm.nih.gov/pubmed/31114154 http://dx.doi.org/10.2147/BTT.S179006 |